State University of New York   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Albany NY United States (1948)

Organization Overview

First Clinical Trial
1977
NCT00000492
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

State University of New York | State University of New York College of Optometry | The State University of New York

Active Ingredients

Drugs in Phase 4 Trials (31)

armodafinil (nuvigil) (1 trial)

atomoxetine (strattera) (1 trial)

atovaquone (mepron) (1 trial)

atropine (2 trials)

buprenorphine (4 trials)

carvedilol (coreg) (2 trials)

chloroquine (1 trial)

cyclobenzaprine (flexeril) (1 trial)

dexmedetomidine (precedex) (1 trial)

doxercalciferol (hectorol) (1 trial)

doxycycline (vibramycin) (1 trial)

gabapentin (neurontin) (1 trial)

interferon alpha-2b (Intron-A) (1 trial)

isoflurane (forane) (1 trial)

lidocaine (xylocaine) (1 trial)

lifitegrast (xiidra) (1 trial)

methadone (methadose) (2 trials)

metoprolol (lopressor) (1 trial)

mirabegron (myrbetriq) (1 trial)

mitoxantrone (novantrone) (1 trial)

naloxone (narcan) (4 trials)

naltrexone (revia) (5 trials)

natalizumab (tysabri) (1 trial)

proguanil (1 trial)

propofol (diprivan) (2 trials)

rabies vaccine (purified chick embryo cell vaccine) (RabAvert) (2 trials)

ribavirin (virazole) (1 trial)

sevoflurane (ultane) (2 trials)

spironolactone (aldactone) (1 trial)

tiagabine (gabitril) (1 trial)

varenicline (chantix) (1 trial)

Drugs in Phase 3 Trials (6)

collagenase clostridium histolyticum (xiaflex) (2 trials)

corticotropin (acthar) (1 trial)

dalfampridine (ampyra) (1 trial)

memantine (namenda) (1 trial)

propranolol (inderal) (1 trial)

valsartan (diovan) (1 trial)

Drugs in Phase 2 Trials (15)

acetylcysteine (mucomyst) (1 trial)

aripiprazole (abilify) (1 trial)

caffeine (2 trials)

cetuximab (erbitux) (1 trial)

chlorhexidine (hibitane) (1 trial)

chromium tripicolinate (1 trial)

clomifene (clomid) (1 trial)

ibuprofen (motrin) (1 trial)

ketorolac (acuvail) (1 trial)

lisdexamfetamine (vyvanse) (1 trial)

minocycline (minocin) (2 trials)

paclitaxel (taxol) (3 trials)

sirolimus (rapamune) (1 trial)

sodium oxybate (xyrem) (1 trial)

testosterone (delatestryl) (1 trial)

Drugs in Phase 1 Trials (6)

amifostine (ethyol) (1 trial)

amiloride (midamor) (1 trial)

carboplatin (paraplatin) (1 trial)

rivaroxaban (xarelto) (1 trial)

valproic acid (depakene) (1 trial)

vasoactive intestinal peptide (1 trial)

Drugs in Other Trials (22)

acamprosate (campral) (1 trial)

albuterol (proventil) (1 trial)

beclomethasone (vanceril) (1 trial)

calcium (1 trial)

cephalexin (keflex) (2 trials)

clindamycin (cleocin) (1 trial)

fish oil (Omegavan) (1 trial)

gingko biloba (1 trial)

linseed oil (1 trial)

magnesium sulfate (Tis-U-Sol) (2 trials)

methylprednisolone (medrol) (1 trial)

metronidazole (flagyl) (1 trial)

mupirocin (bactroban) (1 trial)

nitrous oxide (2 trials)

olanzapine (zyprexa) (1 trial)

olive (1 trial)

oxygen (1 trial)

prednisone (meticorten) (1 trial)

ringer's lactate (1 trial)

risedronate (actonel) (1 trial)

urea (1 trial)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Lung Injury (Phase 1)

Alcoholism (Phase 4)

Alcohol-Related Disorders (Phase 4)

Anxiety Disorders (Phase 4)

Asthma (Phase 2)

Attention Deficit Disorder with Hyperactivity (Phase 4)

Autoimmune Diseases (Phase 4)

Autoimmune Diseases of the Nervous System (Phase 4)

Back Pain (Phase 4)

Behavior, Addictive (Phase 4)

Bipolar Disorder (Phase 4)

Body Weight (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 1)

Carcinoma, Squamous Cell (Phase 2)

Cardiovascular Diseases (Phase 3)

Chronic Pain (Phase 4)

Contracture (Phase 3)

Coronary Disease (Phase 3)

Death, Sudden (Phase 3)

Death, Sudden, Cardiac (Phase 3)

Delirium (Phase 4)

Demyelinating Autoimmune Diseases, CNS (Phase 4)

Depression (Phase 2)

Depressive Disorder (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Disease (Phase 4)

Dupuytren Contracture (Phase 3)

Emergence Delirium (Phase 4)

Fatigue (Phase 4)

Fibromyalgia (Phase 4)

Head and Neck Neoplasms (Phase 2)

Heart Diseases (Phase 3)

Heart Failure (Phase 4)

Hematuria (Phase 1)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis C (Phase 4)

Hyperkinesis (Phase 4)

Hypertension (Phase 4)

Hypogonadism (Phase 2)

Kidney Diseases (Phase 4)

Kidney Failure, Chronic (Phase 4)

Liver Diseases (Phase 4)

Low Back Pain (Phase 4)

Lung Neoplasms (Phase 1)

Lupus Erythematosus, Systemic (Phase 2)

Mental Disorders (Phase 4)

Multiple Sclerosis (Phase 4)

Myelitis (Phase 4)

Myelitis, Transverse (Phase 4)

Myocardial Infarction (Phase 3)

Myocardial Ischemia (Phase 3)

Myofascial Pain Syndromes (Phase 4)

Myopia (Phase 4)

Nervous System Diseases (Phase 4)

Neuromyelitis Optica (Phase 4)

Opioid-Related Disorders (Phase 4)

Pain, Intractable (Phase 4)

Pain, Postoperative (Phase 4)

Phobia, Social (Phase 3)

Pneumonia (Phase 2)

Polyuria (Phase 4)

Problem Behavior (Phase 4)

Psychotic Disorders (Phase 4)

Rabies (Phase 4)

Renal Insufficiency, Chronic (Phase 4)

Respiratory Distress Syndrome (Phase 1)

Respiratory Distress Syndrome, Newborn (Phase 1)

Retinopathy of Prematurity (Phase 2)

Schizophrenia (Phase 4)

Sclerosis (Phase 4)

Sepsis (Phase 1)

Sleep Initiation and Maintenance Disorders (Phase 2)

Stress Disorders, Post-Traumatic (Phase 2)

Substance-Related Disorders (Phase 4)

Syndrome (Phase 1)

Tobacco Use Disorder (Phase 4)

Urinary Bladder Neoplasms (Phase 1)

Ventricular Fibrillation (Phase 3)

Weight Gain (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 70
  • # of Trial APIs: 80